Arkolith/Insider Trading/PCVX/Form 4

Guggenhime Andrew

PRESIDENT AND CFOVaxcyte, Inc. (PCVX) · full profile →Form 4 · filed Jul 6, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$573K
Net Open-Market Flow
-$573K
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 6, 2026Option exercise(M)10K$5.35$54K114K
Jul 6, 2026Sell(S)8K$57.16$452K106K
Jul 6, 2026Sell(S)2K$57.76$121K104K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 6, 2026Option exercise(M)10K—$0227K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001230724-26-000012) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML